{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:26:25Z","timestamp":1781846785175,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.contraception.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T08:39:53Z","timestamp":1464770393000},"page":"701-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-1407","authenticated-orcid":false,"given":"Tara C.","family":"Jatlaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine B.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2016.05.013_bb0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.013_bb0010","first-page":"1","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2016.05.013_bb0015","article-title":"Contraceptive use in the United States","author":"Institute G.","year":"2015","journal-title":"Fact Sheet"},{"key":"10.1016\/j.contraception.2016.05.013_bb0020","first-page":"363","article-title":"Vital signs: trends in use of long-acting reversible contraception among teens aged 15\u201319years seeking contraceptive services\u2014United States, 2005\u20132013","volume":"64","author":"Romero","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.contraception.2016.05.013_bb0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/AOG.0b013e31824aca39","article-title":"Health care provider attitudes and practices related to intrauterine devices for nulliparous women","volume":"119","author":"Tyler","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.05.013_bb0030","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper-genital-tract infection","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2016.05.013_bb0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2016.05.013_bb0040","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition","volume":"62","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2016.05.013_bb0045","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2016.05.013_bb0050","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2016.05.013_bb0055","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.contraception.2016.05.013_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US preventive services task force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2016.05.013_bb0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/jwh.2015.5190","article-title":"Positive testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the risk of pelvic inflammatory disease in IUD users","volume":"24","author":"Birgisson","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.contraception.2016.05.013_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/jwh.2009.1518","article-title":"Long-term, reversible contraception use among high-risk women treated in a university-based gynecology clinic: comparison between IUD and Depo-Provera","volume":"19","author":"Cropsey","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.contraception.2016.05.013_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2007.04.028","article-title":"Intrauterine device use in a high-risk population: experience from an urban university clinic","volume":"197","author":"Campbell","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.05.013_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2015.06.012","article-title":"Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion","volume":"92","author":"Grentzer","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.013_bb0085","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1542-2011.2012.00228.x","article-title":"Criterion-based screening for sexually transmitted infection: sensitivity, specificity, and predictive values of commonly used questions","volume":"57","author":"Murphy","year":"2012","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.contraception.2016.05.013_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.contraception.2006.10.004","article-title":"Identifying appropriate IUD candidates in areas with high prevalence of sexually transmitted infections","volume":"75","author":"Morrison","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.013_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0010-7824(99)00006-2","article-title":"Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates","volume":"59","author":"Morrison","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.013_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(98)00064-X","article-title":"The risk of inadvertent intrauterine device insertion in women carriers of endocervical chlamydia trachomatis","volume":"58","author":"Faundes","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.013_bb0105","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","article-title":"Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease","volume":"120","author":"Sufrin","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.05.013_bb0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.whi.2014.09.006","article-title":"Same-day intrauterine device placement is rarely complicated by pelvic infection","volume":"25","author":"Papic","year":"2015","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.contraception.2016.05.013_bb0115","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2016.05.013_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006250-199102000-00019","article-title":"Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices","volume":"77","author":"Toivonen","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2016.05.013_bb0125","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae\u20142014","volume":"63","author":"Centers for Disease Control","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2016.05.013_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.013_bb0135","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2016.05.013_bb0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/OLQ.0b013e31829529eb","article-title":"Sexually transmitted infection prevalence in a population seeking no-cost contraception","volume":"40","author":"McNicholas","year":"2013","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.contraception.2016.05.013_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.contraception.2014.02.007","article-title":"Routine counseling about intrauterine contraception for women seeking emergency contraception","volume":"90","author":"Schwarz","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2016.05.013_bb0150","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/humrep\/det330","article-title":"Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle","volume":"28","author":"Turok","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2016.05.013_bb0155","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.contraception.2010.06.001","article-title":"A pilot study of the copper T380a IUD and oral levonorgestrel for emergency contraception","volume":"82","author":"Turok","year":"2010","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782416301093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T09:58:59Z","timestamp":1536659939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782416301093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0010782416301093"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2016.05.013","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety of intrauterine contraception initiation among women with current asymptomatic cervical infections or at increased risk of sexually transmitted infections","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}